BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 32298458)

  • 1. Is antibody-dependent enhancement playing a role in COVID-19 pathogenesis?
    Negro F
    Swiss Med Wkly; 2020 Apr; 150():w20249. PubMed ID: 32298458
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody-dependent enhancement of coronavirus.
    Wen J; Cheng Y; Ling R; Dai Y; Huang B; Huang W; Zhang S; Jiang Y
    Int J Infect Dis; 2020 Nov; 100():483-489. PubMed ID: 32920233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-dependent enhancement and COVID-19: Moving toward acquittal.
    Yager EJ
    Clin Immunol; 2020 Aug; 217():108496. PubMed ID: 32526272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A perspective on potential antibody-dependent enhancement of SARS-CoV-2.
    Arvin AM; Fink K; Schmid MA; Cathcart A; Spreafico R; Havenar-Daughton C; Lanzavecchia A; Corti D; Virgin HW
    Nature; 2020 Aug; 584(7821):353-363. PubMed ID: 32659783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine.
    Peeples L
    Proc Natl Acad Sci U S A; 2020 Apr; 117(15):8218-8221. PubMed ID: 32229574
    [No Abstract]   [Full Text] [Related]  

  • 6. Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures.
    Eroshenko N; Gill T; Keaveney MK; Church GM; Trevejo JM; Rajaniemi H
    Nat Biotechnol; 2020 Jul; 38(7):789-791. PubMed ID: 32504046
    [No Abstract]   [Full Text] [Related]  

  • 7. What about the original antigenic sin of the humans versus SARS-CoV-2?
    Roncati L; Palmieri B
    Med Hypotheses; 2020 Sep; 142():109824. PubMed ID: 32408068
    [No Abstract]   [Full Text] [Related]  

  • 8. Coronavirus vaccine-associated lung immunopathology-what is the significance?
    Bottazzi ME; Strych U; Hotez PJ; Corry DB
    Microbes Infect; 2020 Oct; 22(9):403-404. PubMed ID: 32599077
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies.
    Lee WS; Wheatley AK; Kent SJ; DeKosky BJ
    Nat Microbiol; 2020 Oct; 5(10):1185-1191. PubMed ID: 32908214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines: Setting Expectations Appropriately.
    Heininger U
    Pediatr Infect Dis J; 2020 Jul; 39(7):e123-e124. PubMed ID: 32427644
    [No Abstract]   [Full Text] [Related]  

  • 11. Out of the frying pan and into the fire? Due diligence warranted for ADE in COVID-19.
    Coish JM; MacNeil AJ
    Microbes Infect; 2020 Oct; 22(9):405-406. PubMed ID: 32590062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Balancing Expediency and Scientific Rigor in Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development.
    Graepel KW; Kochhar S; Clayton EW; Edwards KE
    J Infect Dis; 2020 Jun; 222(2):180-182. PubMed ID: 32365191
    [No Abstract]   [Full Text] [Related]  

  • 13. China's coronavirus vaccines are leaping ahead - but face challenges as virus wanes.
    Cyranoski D
    Nature; 2020 Aug; 584(7819):17-18. PubMed ID: 32737453
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of IgG Fc receptors in antibody-dependent enhancement.
    Bournazos S; Gupta A; Ravetch JV
    Nat Rev Immunol; 2020 Oct; 20(10):633-643. PubMed ID: 32782358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid COVID-19 vaccine development.
    Graham BS
    Science; 2020 May; 368(6494):945-946. PubMed ID: 32385100
    [No Abstract]   [Full Text] [Related]  

  • 16. Audio Interview: Capitalizing on Immune Responses to Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 May; 382(21):e93. PubMed ID: 32433859
    [No Abstract]   [Full Text] [Related]  

  • 17. [Strategies for vaccine development of COVID-19].
    Yang L; Tian D; Liu W
    Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):593-604. PubMed ID: 32347054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines.
    Salvatori G; Luberto L; Maffei M; Aurisicchio L; Roscilli G; Palombo F; Marra E
    J Transl Med; 2020 Jun; 18(1):222. PubMed ID: 32493510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2: A New Song Recalls an Old Melody.
    Subbarao K
    Cell Host Microbe; 2020 May; 27(5):692-694. PubMed ID: 32407706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral Emerging Diseases: Challenges in Developing Vaccination Strategies.
    Trovato M; Sartorius R; D'Apice L; Manco R; De Berardinis P
    Front Immunol; 2020; 11():2130. PubMed ID: 33013898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.